Revolutionizing CAR T-Cell Therapy: Cellectis’ Groundbreaking Discovery Published in Nature Communications

New Biotechnology Company Making Waves in the Industry June 30, 2022 Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company June 30, 2022 – Cellectis is making headlines in the biotechnology industry with its innovative approaches to clinical-stage research. The company, known for its cutting-edge technology and groundbreaking discoveries, is creating…

Read More

Attention Investors: Don’t Miss the Deadline for Potential Recovery in Mullen Automotive Inc. (formerly Net Element Inc.) Lawsuit!

Welcome to the Future of Automotive Innovation Robbins Geller Rudman & Dowd LLP Announcement SAN DIEGO, June 30, 2022 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Mullen Automotive, Inc. f/k/a N… Exciting news in the automotive industry! Robbins Geller Rudman & Dowd LLP has announced an important…

Read More

Univest Securities LLC Fully Exercises Underwriters’ Over-Allotment Option for Bit Origin Ltd’s Public Offering on NASDAQ: BTOG

Univest Securities, LLC June 29, 2022 Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, is a full-service investment bank and securities firm Univest Securities, LLC (“Univest”) is making waves in the financial industry as a prominent member of FINRA and SIPC. As a full-service investment bank and securities firm, Univest offers a wide…

Read More